What is it about?
This study aimed to investigate short-term outcomes of patients rated as different severities on admission, and to identify risk factors for progression, thereby, help the management of COVID-19 in clinical practice.
Featured Image
Why is it important?
Coronavirus Disease 2019 (COVID-19) has now become a worldwide health concern. The severity of COVID-19 was classified as mild, moderate, severe and critical. To date, there were a few studies focused on the clinical course and outcome of critical cases. However, information regarding outcomes of mild to moderate cases are lacking, despite the fact that mild to moderate cases accounted for approximately 80% of laboratory-confirmed patients. Our study provides detailed information regarding short-term outcomes of COVID-19 patients who were rated as different severities on admission, meanwhile, risk factors for progression were identified.
Perspectives
We believe findings in the present study would be helpful to prevent progression in an earlier stage for the general COVID-19 patients and could be a supplement to previous studies that focused on the composite endpoint (one or more of death, admission to the ICU, the use of mechanical ventilation) of COVID-19.
Kefang Lai
Read the Original
This page is a summary of: Short-term outcomes of COVID-19 and risk factors for progression, European Respiratory Journal, April 2020, European Respiratory Society (ERS),
DOI: 10.1183/13993003.00990-2020.
You can read the full text:
Contributors
The following have contributed to this page
